- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Embecta Corp (EMBC)
The Embecta share price today is 5.10, view NASDAQ EMBC stock exchange data. Track the latest Embecta share price with real-time updates on EMBC stock performance including market cap, day range, 52-week range and dividend yield. Access EMBC charts, earnings dates and analyst estimates to support your investment decisions.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.07
5.38
52 wk Range
2.77
15.55
EMBC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.075.38
52 wk Range
2.7715.55
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.78%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.78%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EMBC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
4.00
Downside
-21.57%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Analyst Ratings
0 Buy
3 Hold
1 Sell
Ratings:
4 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 4.00
(-21.57% Downside)
Embecta Corp Earnings Call Summary for Q3/2026
- Embecta Q3 adjusted EPS of $0.56 beat estimates of $0.27 by 107%; revenue of $271.7M topped forecasts by 6.88%, driving shares up 13.43% premarket.
- Company raised FY2026 adjusted operating margin guidance to 23.5%-24% from 22.25%-23.25% and lifted adjusted EPS outlook to $1.80-$1.90 from $1.55-$1.75.
- Revenue fell 8.1% YoY to $272M; U.S. sales dropped 24.6% while international grew 11.5%, reflecting continued domestic market pressure offset by overseas strength.
- Owen Mumford acquisition completed in May expands addressable market into $2.4B auto-injector segment growing at double-digit rates beyond legacy insulin business.
- Net leverage improved to 3.7x with $53M debt repayment; management deferred 2027 guidance, citing need to assess macro trends and complete integration efforts.
Last Updated: 07-08-2026, 06:16 pm
Read Full TranscriptEarnings
Latest Release
07-08-2026
EPS / Forecast
0.56 / 0.27
Revenue / Forecast
271.7M / 254.22M
Compare EMBC to Peers and Sector
Metrics to compare | EMBC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEMBCPeersSector | |
|---|---|---|---|---|
P/E Ratio | 3.3x | −1.4x | −0.3x | |
PEG Ratio | 0.98 | −0.25 | 0.00 | |
Price/Book | −0.5x | 1.9x | 2.6x | |
Price / LTM Sales | 0.3x | 1.2x | 3.1x | |
Upside (Analyst Target) | −22.8% | 35.6% | 50.4% | |
Fair Value Upside | Unlock | 25.8% | 6.4% | Unlock |
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Embecta (EMBC) Share Price Today?
The Embecta share price today is 5.10.
What is the current Embecta (EMBC) share price and day range?
As of 19-08-2026, the Embecta share price is 5.10, with a previous close of 5.13. The share price has ranged from 5.07 to 5.38 today, while the 52-week range spans from 2.77 to 15.55.
What Is the Embecta Market Cap?
As of today, Embecta market cap is 288.96M.
Does Embecta Pay Dividends? What's The Current Dividend Yield?
The Embecta dividend yield is 0.78%.
What Is the Embecta (EMBC) Share Price Target?
The average 12-month share price target for Embecta is 4.00, with a high estimate of 5 and a low estimate of 3. 0 analysts recommend buying, while 1 suggest selling, with an overall rating of Neutral and -21.57% Downside potential.
What Is Embecta's Earnings Per Share (TTM)?
The Embecta EPS (TTM) is 1.47.
When Is the Next Embecta Earnings Date?
Embecta will release its next earnings report on 01-12-2026.
From a Technical Analysis Perspective, Is EMBC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Embecta Trade On?
Embecta is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Embecta?
The stock symbol for Embecta is "EMBC."
How Many Times Has Embecta Stock Split?
Embecta has split 0 times.
How Many Employees Does Embecta Have?
Embecta has 1850 employees.
What Is the EMBC Premarket Price?
EMBC's last pre-market stock price is 5.08. The pre-market share volume is 5,290.00, and the stock has changed by -0.05, or -0.97%.
What Is the EMBC After Hours Price?
EMBC's last after hours stock price is 5.11, the stock has changed by 0.01, or 0.20%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.